Advocating an Evolution: Interview with the Alliance for Regenerative Medicine

摘要

In a 2006 report, the US Department of Health and Human Services hailed regenerative medicine as "the vanguard of 21st century healthcare" and "the first truly interdisciplinary field that utilizes and brings together nearly every field in science" (l). To fuel support for regulatory, legislative, and reimbursement initiatives in this new therapeutic class, a small group of scientists, life science business executives, patient advocates, and other experts formed the Alliance for Regenerative Medicine(ARM, http:// alliancerm.org). Starting with 17 charter members, the organization now includes more than 130 participants. Here, I discuss ARM's objectives and current projects with cofounder and executive director Michael Werner and managing director Morrie Ruffin.